release through IP3Rs in the form of discrete transient signals is necessary for VSM cell proliferation. To investigate this hypothesis, we used mouse cerebral arteries to design an organ culture system that permitted examination of Ca 2ϩ dynamics in native tissue. Explanted arteries were cultured in normal medium with 10% FBS, and appearance of individual VSM cells migrating from explanted arteries (outgrowth cells) was tracked daily. Initial exposure to 10% FBS increased Ca 2ϩ waves in myocytes in the arteries that were blocked by the IP3R antagonist 2-aminoethoxydiphenylborate (2-APB). Inhibition of IP 3R opening (via 100 M 2-APB, 10 M xestospongin C, or 25 M U-73122) dramatically reduced outgrowth cell number compared with untreated or ryanodine-treated (10 M) arteries. Consistent with this finding, 2-APB inhibited cell proliferation, as measured by reduced proliferating cell nuclear antigen immunostaining within 48 h of culture but did not inhibit cell migration. These results indicate that activation of IP3R Ca 2ϩ release is required for VSM cell proliferation in these arteries. calcium signaling; explant culture; calcium channels; sarcoplasmic reticulum INTRACELLULAR CALCIUM, an essential regulator of vascular smooth muscle (VSM) function, controls numerous aspects of smooth muscle cell physiology, including contraction and proliferation (27) (8, 29, 34 ). The implication is that a proliferation-inducing agonist causes an increase in [Ca 2ϩ ] cyt by signaling the release of Ca 2ϩ from the SR (3, 36). In the short term, a change in Ca 2ϩ signaling may be sufficient to stimulate VSM cells to revert to the proliferating/synthetic phenotype, whereas longer-term changes in expression of IP 3 R, VDCC L , and RyR may reflect cellular adaptations to the new Ca 2ϩ signaling environment. For example, evidence from in vitro culture studies shows that IP 3 R expression is maintained (31, 32, 36) , whereas VDCC L function (13, 18) and RyR expression (32) are lost, on conversion to the proliferating/ synthetic phenotype.
release through IP3Rs in the form of discrete transient signals is necessary for VSM cell proliferation. To investigate this hypothesis, we used mouse cerebral arteries to design an organ culture system that permitted examination of Ca 2ϩ dynamics in native tissue. Explanted arteries were cultured in normal medium with 10% FBS, and appearance of individual VSM cells migrating from explanted arteries (outgrowth cells) was tracked daily. Initial exposure to 10% FBS increased Ca 2ϩ waves in myocytes in the arteries that were blocked by the IP3R antagonist 2-aminoethoxydiphenylborate (2-APB). Inhibition of IP 3R opening (via 100 M 2-APB, 10 M xestospongin C, or 25 M U-73122) dramatically reduced outgrowth cell number compared with untreated or ryanodine-treated (10 M) arteries. Consistent with this finding, 2-APB inhibited cell proliferation, as measured by reduced proliferating cell nuclear antigen immunostaining within 48 h of culture but did not inhibit cell migration. These results indicate that activation of IP3R Ca 2ϩ release is required for VSM cell proliferation in these arteries. calcium signaling; explant culture; calcium channels; sarcoplasmic reticulum INTRACELLULAR CALCIUM, an essential regulator of vascular smooth muscle (VSM) function, controls numerous aspects of smooth muscle cell physiology, including contraction and proliferation (27) . Ca 2ϩ signaling in smooth muscle can exhibit a number of unique signatures. Changes in Ca 2ϩ entry through L-type voltage-dependent Ca 2ϩ channels (VDCC L ) in the plasma membrane lead to graded changes in average ("global") Ca 2ϩ throughout the cell's cytoplasm. Opening of ryanodinesensitive, Ca 2ϩ -sensitive Ca 2ϩ release channels [ryanodine receptors (RyRs)] in sarcoplasmic reticulum (SR) membrane can cause local Ca 2ϩ transients ("Ca 2ϩ sparks"), which activate large-conductance, Ca 2ϩ -sensitive K ϩ (BK) channels to close VDCC L s through membrane potential hyperpolarization (5) . Vasoconstrictors can cause intracellular Ca 2ϩ waves through activation of phospholipase C (PLC), production of inositol 1,4,5-trisphosphate (IP 3 ), and activation of IP 3 receptors (IP 3 Rs) in SR membrane (3) . These Ca 2ϩ signals differentially regulate ion channels such as the BK channel, contraction through myosin light chain kinase, and activation of Ca 2ϩ -dependent transcription factors such as cAMP response element binding protein and nuclear factor of activated T cells (NFAT) (4, 5) .
The roles of IP 3 Rs, VDCC L s, and RyRs in regulating VSM phenotype are unclear. VSM cells undergo phenotype modulation in response to vascular damage, exhibiting the "synthetic" phenotype distinguished by the downregulation of contractile smooth muscle cell differentiation markers (25) . The initiation for phenotype change is dependent on the passage of VSM cells through various cell cycle checkpoints that require specifically timed alterations in the levels of cytosolic Ca ] cyt ) (3). Several studies have suggested that Ca 2ϩ -dependent cell cycle events require the release of Ca 2ϩ from intracellular stores (8, 29, 34) . The implication is that a proliferation-inducing agonist causes an increase in [Ca 2ϩ ] cyt by signaling the release of Ca 2ϩ from the SR (3, 36) . In the short term, a change in Ca 2ϩ signaling may be sufficient to stimulate VSM cells to revert to the proliferating/synthetic phenotype, whereas longer-term changes in expression of IP 3 R, VDCC L , and RyR may reflect cellular adaptations to the new Ca 2ϩ signaling environment. For example, evidence from in vitro culture studies shows that IP 3 R expression is maintained (31, 32, 36) , whereas VDCC L function (13, 18) and RyR expression (32) are lost, on conversion to the proliferating/ synthetic phenotype.
Given the potential role of different, modulated Ca 2ϩ signals in differential regulation of proliferation, we hypothesized that an alteration in intracellular Ca 2ϩ signaling is involved in eliciting VSM cells to enter the cell cycle and begin proliferation. One shortcoming of previous experiments utilizing multipassaged VSM cells and established VSM cell lines is that each subsequent generation of cells progressively loses expression of key proteins that characterize the differentiated phenotype. To establish a model that more closely resembles the cellular dynamics of in vivo VSM cell migration and proliferation, we used explanted mouse cerebral arteries in organ culture to design an in vitro system. This approach permits tracking of VSM cell proliferation and migration and allows for simultaneous, high-resolution examination of VSM Ca 2ϩ dynamics in the intact artery and in migratory cells. Our results suggest that an elevated frequency of IP 3 R-mediated Ca 2ϩ waves is required for VSM cell proliferation and, furthermore, that RyR-mediated Ca 2ϩ release inhibits this proliferation.
MATERIALS AND METHODS

Drugs and solutions.
Physiological saline solution [PSS; in mmol/l: 118.5 NaCl, 4.7 KCl, 1.2 MgCl2, 1.18 KH2PO4, 0.026 EDTA, 24 NaHCO3, 11 glucose, and 2 CaCl2 (pH 7.4)] was continuously bubbled with 95% O2-5% CO2 and heated to 37°C. Culture medium consisted of DMEM (Mediatech, Herndon, VA), penicillin-streptomycin (100 U and 100 g/ml, respectively; Invitrogen, Carlsbad, CA), and 4 mM L-glutamate (Mediatech) and was supplemented with FBS (Invitrogen) as indicated. HEPES buffer solution contained (in mmol/l) 134 NaCl, 6 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, and 10 glucose, with pH adjusted to 7.4 with NaOH. Caffeine, diltiazem, and thapsigargin were obtained from Sigma-Aldrich (St. Louis, MO); 2-aminethoxydiphenylborate (2-APB), xestospongin C, and U-73122 from Calbiochem (EMD Biosciences, San Diego, CA); and ryanodine from LC Laboratories (Woburn, MA).
Tissue preparation. Adult male C57BL/6 mice (25-31 g; Charles River Laboratories) were euthanized with an overdose of pentobarbital solution (200 mg/kg ip) and then thoracotomized in accordance with National Institutes of Health Guidelines for the Care and Use of Laboratory Animals (NIH Publication No. 1985) and as approved by the Institutional Animal Use and Care Committee of the University of Vermont. Posterior 70-to 120-m diameter cerebral and cerebellar arteries were removed from the brain and placed in oxygenated, ice-cold PSS. After the connective tissue was removed, intact segments of the arteries were slipped over a glass cannula as previously described (16) for same-day [Ca 2ϩ ]cyt measurements or cut into segments for culture.
Explant cultures. Arterial segments were cut into 500-m lengths and transferred to two-well chambered coverslips (Lab-Tek, Nalge Nunc, Rochester, NY) containing culture medium supplemented with 10% or 0.1% FBS and drugs as indicated. The cultures were maintained in a water-jacketed cell incubator at 37°C under 5% CO2 in air. Culture medium and drugs were replaced daily. To stimulate outgrowth of VSM cells, arteries on glass coverslips were exposed to culture medium with 10% FBS (30) . Typically, individual VSM cells migrating from the explanted arterial segments (outgrowth cells) were observed by 8 h of exposure to 10% FBS. Outgrowth cell numbers were obtained by averaging the mean daily counts from three 512-m 2 fields per cultured artery segment. Only VSM cells with nuclei clearly separated from the explanted artery segment were counted as outgrowth.
Immunofluorescence. Arteries were fixed on the chambered coverslips with 4% formaldehyde in PSS (pH 7.4). After permeabilization and block of nonspecific binding sites with goat serum, arteries were incubated in a solution of primary antibody diluted in 5% goat serum-phosphate-buffered saline overnight at 4°C. The following primary antibodies were used: a rat monoclonal antibody against Ki-67 (1:25 dilution; DakoCytomation, Carpinteria, CA) with a mouse monoclonal antibody to smooth muscle ␣-actin (1:10 dilution; Research Diagnostics, Flanders, NJ); a mouse monoclonal antibody against proliferating cell nuclear antigen (PCNA, 1:500 dilution; BD Biosciences PharMingen, San Diego, CA); or a mouse monoclonal antibody against smooth muscle myosin heavy chain (smMHC) isoforms SM1 and SM2 (1:100 dilution; Sigma-Aldrich). After several washes in 0.1 M phosphate-buffered saline, the secondary antibodies Alexa Fluor 568 goat anti-mouse (1:200 dilution; Molecular Probes) and/or Alexa Fluor 647 goat anti-rat (1:200 dilution; Molecular Probes) were applied for 2 h at room temperature. Nuclei were stained with the fluorescent nucleic acid dye Sytox (1:3,000 dilution; Molecular Probes). After several washes, the chamber sides were removed from the coverslip, which was then inverted and mounted (Citiflour, Leicester, UK) onto glass slides. Outgrowth cells and explanted arterial segments were visualized using a laser confocal scanning microscope (model MRC 1000, Bio-Rad Laboratories, Hercules, CA). Specificity of immune staining was confirmed by the absence of fluorescence in arteries incubated with primary or secondary antibodies alone. For scoring of PCNA-and Ki-67-positive cells, multiple fields for each cultured artery segment were imaged and counted under double-blind conditions with the aid of Metamorph software (Universal Imaging, Downington, PA).
Confocal Ca 2ϩ imaging. Transient Ca 2ϩ signals were examined in the wall of intact artery segments or in VSM outgrowth cells of artery segments cultured for 5 days. Both preparations were incubated with the Ca 2ϩ -sensitive fluorescent dye fluo 4-AM (10 M) and Pluronic acid (2.5 g/ml; Molecular Probes) dissolved in HEPES buffer for 60 min at 21-23°C (intact arteries) or culture medium with 0.1% FBS in a CO 2 incubator for 30 min at 37°C (VSM outgrowth cells). After loading, a krypton-argon laser at 480 nm was used to excite the fluo 4, and the emitted light was detected at Ͼ500-nm wavelengths with a laser scanning confocal microscope (OZ, Noran Instruments) using Prairie Technologies ( Ratiometric Ca 2ϩ measurements. Changes in VSM [Ca 2ϩ ]cyt were examined in the wall of intact pial arteries. Artery segments were loaded with the ratiometric Ca 2ϩ -sensitive fluorescent dye fura 2-AM (2 M; Molecular Probes) and Pluronic acid (2.5 g/ml) dissolved in HEPES buffer for 60 min, as previously described (17) . Fluorescence was measured using a photomultiplier system (IonOptix, Milton, MA) attached to a Nikon Diaphot microscope (ϫ40 Fluor lens) in which background-corrected ratios of 510-nm emission were obtained at a sampling rate of 15 Hz from arteries alternately excited at 340 and 380 nm. Ratios were measured from background-corrected images of the 510-nm emission. Arterial wall VSM [Ca 2ϩ ]cyt was calculated using the following equation (11) 
where Kd is apparent dissociation constant and Rmin and Rmax are ratios of emission signals under Ca 2ϩ -free and Ca 2ϩ -saturated conditions, respectively.
At the end of every experiment, Rmin and Rmax were determined from ionomycin-treated arteries, and ␤ was determined. A Kd of 282 nM Ca 2ϩ was used for fura 2 (17) . Experimental protocols were started after an additional 20-min equilibration period to allow intracellular deesterification of fura 2-AM.
Migration assay. Arterial explant cultures were placed in an open chamber with atmospheric and temperature controls. Conditions were maintained at 37°C in 5% CO 2 in air for 6 -8 h. After a 30-min adjustment period, images were obtained and processed using a Deltavision RT system (Applied Precision, Issaquah, WA) at 10-min intervals. After 3-4 h, culture medium ϩ 10% FBS was replaced with fresh medium ϩ 10% FBS with or without drug. Migration distances for individual cells were calculated by tracking movement of nuclei over time.
Statistics. Values are means Ϯ SE where applicable. Unless otherwise noted, n is the number of explants. For all except Ca 2ϩ imaging data, significance was tested at the 95% (P Ͻ 0.05) confidence level by one-way ANOVA followed by appropriate comparisons (Tukey's procedure or Kruskal-Wallis ANOVA on ranks). Transient and whole cell Ca 2ϩ imaging data were tested using one-way repeated-measures ANOVA (Holm-Sidak method).
RESULTS
Outgrowth cells from arterial segments are VSM cells.
Immunofluorescence staining was performed on a subset of cultured arterial segments to confirm that outgrowth cells were VSM in origin and actively proliferating (28) . All cells were positive for the smooth muscle markers smooth muscle ␣-actin and smMHC (data not shown). Ten percent of cells within the explanted artery segments and 54% of VSM outgrowth cells (individual VSM cells migrating from the explanted artery segments) were positive for the proliferation indicator Ki-67 (Fig. 1) .
Serum induces Ca 2ϩ waves in arteries. Activation of IP 3 Rs by vasoconstrictors leads to a characteristic increase in Ca 2ϩ waves in arterial myocytes (14) . We therefore examined the effects of serum on Ca 2ϩ signals in intact cerebral arteries (Fig.  2) . In the absence of serum, arteries exhibited primarily Ca 01191.2004.DC1.] FBS contains numerous mitogens, which stimulate PLC through G protein-coupled receptors (e.g., catecholamines, endothelin-1, and thrombin) or by activation of protein tyrosine kinases (e.g., platelet-derived growth factor, epidermal growth factor, and insulin-like growth factor) (2, 26) . These data imply that FBS stimulates the production of IP 3 through receptor-mediated PLC cleavage of phosphatidylinositol 4,5-bisphosphate to IP 3 and diacylglycerol (4) . In contrast to the substantial effects of FBS on Ca 2ϩ waves, the frequency of Ca 2ϩ sparks in PSS was not significantly altered by FBS or the further addition of 2-APB or U-73122 (Table 1) . Addition of either 2-APB or U-73122 alone failed to significantly affect the frequency of Ca 2ϩ sparks or Ca 2ϩ waves (Table 1) . FBS treatment could potentially increase whole cell cytosolic (i.e., global) Ca 2ϩ , which has been previously associated with the initiation of VSM cell proliferation (4). To dissect the effects of global Ca 2ϩ elevations and Ca 2ϩ waves, fura 2-loaded cerebral arteries were exposed to FBS and then to 2-APB, xestospongin C, U-73122, and diltiazem. FBS induced a sustained increase in [Ca 2ϩ ] cyt , which was not decreased by subsequent addition of 2-APB, xestospongin C, or U-73122 (Fig. 3) , we cultured artery segments in medium with 10% FBS or medium with 10% FBS ϩ thapsigargin and tracked the effect on VSM cell proliferation over 5 days. Thapsigargin inhibits SR Ca 2ϩ reuptake, leading to SR Ca 2ϩ store depletion (19) . Thapsigargin drastically inhibited VSM cell outgrowth to a level similar to that observed in 0.1% (low) FBS (Fig. 4) . These data indicate that SR Ca 2ϩ stores are necessary for VSM cell outgrowth from cultured arteries.
It is also possible that extracellular Ca 2ϩ entry, through VDCC L , may have an impact on proliferation. To examine this possibility, we treated a subset of explants from the start of culture though day 5 with diltiazem, a very specific VDCC L inhibitor (Fig. 4) . Although diltiazem reduced FBS-induced elevations in global Ca 2ϩ (Table 1) , it did not affect outgrowth, suggesting that extracellular Ca 2ϩ entry through VDCC L s is not an absolute requirement for VSM cell outgrowth.
IP 3 Rs play an important role in VSM cell outgrowth. Two types of SR Ca 2ϩ release channels are present in VSM: IP 3 Rs and RyRs. Thapsigargin depletion of SR Ca 2ϩ stores affects Ca 2ϩ release through both receptor types. We first focused on IP 3 Rs for several reasons: 1) exposure of arteries to 10% FBS induced significant changes in Ca 2ϩ waves; 2) 10% FBS most likely stimulates VSM cell proliferation via receptor-mediated PLC activation; and 3) evidence from studies using traditional cell culture lines suggests that IP 3 R expression is preserved during dedifferentiation (32, 36) . Consequently, to determine whether FBS stimulates VSM cell outgrowth by signaling through the PLC pathway, we utilized an inhibitor (U-73122) of PLC-␤ and PLC-␥ (12). U-73122 significantly inhibited VSM cell outgrowth (Fig. 5) , indicating PLC dependence.
To explore further the role of IP 3 Rs, the effects of two inhibitors of IP 3 Rs, 2-APB and xestospongin C, were tested on VSM cell outgrowth. VSM cell outgrowth was effectively inhibited by both drugs (Fig. 5) . Although 2-APB has other effects (7, 21, 22) , 2-APB and xestospongin C block IP 3 Rs (7, 21, 22) . Taken together with the inhibitory effects of thapsigargin and U-73122, these data show that VSM cell outgrowth is dependent on SR Ca 2ϩ release through IP 3 Rs. Smooth muscle SR contains another Ca 2ϩ release channel, the RyR, which is activated by cytoplasmic Ca 2ϩ . Ryanodine, which selectively inhibits Ca 2ϩ release from SR RyRs, failed to prevent VSM cell outgrowth (Fig. 5) . In fact, ryanodine increased the number of VSM outgrowth cells over 5 days. This suggests that RyR activity may block VSM cell outgrowth, a role in opposition to that of IP 3 Rs.
IP 3 R activity is necessary for VSM cell proliferation. Reductions in VSM cell outgrowth from cultured arteries by IP 3 R blockers could be attributed to inhibition of cell proliferation and/or cell migration. To examine cell proliferation, arteries were treated with 2-APB for up to 48 h and then immunostained for the proliferation indicator protein PCNA (red) and counterstained with Sytox to identify nuclei. IP 3 R blockade with 2-APB dramatically reduced the number of PCNA-positive nuclei in the walls of the explanted arteries and inhibited VSM cell outgrowth (Fig. 6 ). These data suggest that IP 3 Rdependent proliferation is responsible, at least in part, for our observations of VSM cell outgrowth.
To test whether IP 3 R blockade via 2-APB affects the ability of VSM outgrowth cells to migrate, we used phase-contrast imaging of day 5 artery cultures. This allowed for observation of the active migration of VSM outgrowth cells under control conditions (culture medium ϩ 10% FBS) and immediately after application of 2-APB. Migration rates were unaffected by 2-APB over a 160-min period ( Fig. 7 ; see supplemental Movie 2). Therefore, it appears that IP 3 R signaling is required for proliferation of VSM cell outgrowth, rather than migration. waves, but not Ca 2ϩ sparks, were observed in these cells (Fig .   Fig. 4 . Depletion of sarcoplasmic reticulum Ca 2ϩ store inhibits VSM cell outgrowth. All experiments were performed in culture medium ϩ 10% FBS ϩ diltiazem or thapsigargin or in culture medium ϩ 0.1% FBS. Top: representative images. Scale bar, 100 m. Bottom: summary graph. Cell numbers were obtained by averaging mean daily counts from three 512-m 2 fields per artery culture. †Significantly less than control (P Ͻ 0.05). 8; see supplemental Movie 3). The lack of Ca 2ϩ spark activity in these cells supports the hypothesis that outgrowth cells have reduced RyR activity and that the spontaneous Ca 2ϩ transients are due to agonist-induced opening of IP 3 Rs.
DISCUSSION
The major Ca 2ϩ entry pathways (VDCCs, RyRs, and IP 3 Rs) into the smooth muscle cytoplasm mediate distinctly different Ca 2ϩ signals and are differentially regulated (15) . Activation of VDCC L s leads to a uniform (i.e., global) elevation of [Ca 2ϩ ] cyt . RyR activation largely manifests as stationary, local elevation of Ca 2ϩ (Ca 2ϩ spark), which activates closely opposed BK channels, leading to membrane potential hyperpolarization and decreased VDCC L activity (23) . Finally, IP 3 R stimulation is dependent on receptor-mediated PLC activation, which elevates levels of IP 3 , causing Ca 2ϩ waves to propagate through smooth muscle cells (14, 15) .
Our results (Fig. 2 -ATPase (SERCA) with thapsigargin also inhibited proliferation, further implicating SR Ca 2ϩ stores in this process. Interestingly, blocking VDCC L s with diltiazem had no effect on proliferation (Fig. 4) , whereas inhibition of RyRs augmented proliferation (Fig. 5) . One mechanism that may account for the potentiating effect of RyR inhibition is that treatment of explanted arteries with ryanodine stimulates proliferation by elevating average [Ca 2ϩ ] cyt through increased VDCC L activation (17) and, thereby, increases IP 3 -mediated Ca 2ϩ release through an elevation of SR Ca 2ϩ load. Alternatively, if Ca 2ϩ release from RyRs and IP 3 Rs is dependent on a shared Ca 2ϩ pool, it is possible that blockade of one channel type provides a greater driving force for SR Ca 2ϩ release from the unblocked channel.
It is important to note that inhibition of VSM cell outgrowth by thapsigargin and IP 3 R blockade is due to prevention of VSM cell proliferation, rather than migration. Although our results do not rule out the possibility that IP 3 R-mediated Ca is required to initiate migration, they do suggest that IP 3 Rmediated Ca 2ϩ release is required for proliferation but not for migratory activity per se. Furthermore, if the initial event in outgrowth cell appearance was migration of VSM cells from the cultured artery, rather than proliferation within the arterial wall, then one would expect to see outgrowth at a rate at least equal to the appearance of PCNA-positive cells within the artery wall. Figure 6 shows that this is not the case: the number of PCNA-positive cells clearly exceeded the number of outgrowth cells over the first 48 h of culture. The near-complete absence of PCNA-positive cells in the 2-APB-treated arteries suggests that the primary initial event in VSM cell outgrowth is cell proliferation.
The important role of IP 3 Rs in VSM cell proliferation has also been demonstrated by Wang et al. (36) . Utilizing the A7r5 VSM cell line, they showed that suppressing expression of the dominant IP 3 R subtype (type I) in VSM cells via an antisense strategy resulted in a loss of IP 3 -induced Ca 2ϩ release and a failure to proliferate (24) . Our findings demonstrate that SR Ca 2ϩ released through IP 3 Rs, in the form of Ca 2ϩ waves, is required for dedifferentiation of native VSM cells from the contractile to the proliferative state. This observation is consistent with a central role for SR Ca 2ϩ in controlling VSM cell proliferation, as suggested by previous studies showing that SERCA activity is necessary for serum-induced cell growth (34) and that emptying of SR Ca 2ϩ stores via SERCA inhibition triggers entry of cells into a quiescent state (29) .
Although the exact physiological role of Ca 2ϩ waves remains elusive, our laboratory has reported a potential role for Ca 2ϩ wave signaling in regulating nuclear localization of the Ca 2ϩ -activated transcription factor NFAT. We found that blocking IP 3 Rs prevented NFATc3 nuclear localization (9) . NFAT requires dephosphorylation by the Ca 2ϩ -activated enzyme calcineurin to move into the nucleus and become transcriptionally active (1) . By blocking calcineurin activity with cyclosporin A or FK-506, Wada et al. (33) found that they could inhibit the endogenous expression of smMHC in differentiated VSM cells, suggesting that the calcineurin pathway is activated during differentiation of VSM cells and is required for smMHC expression. Similarly, it is possible that the alteration in IP 3 R-mediated Ca 2ϩ signaling that precedes VSM cell proliferation is linked to stimulation of proliferation through effects on Ca 2ϩ -sensitive transcriptional regulators. To this end, Lipskaia et al. (20) found that treating cultured VSM cells with very-low-density lipoproteins induces a calcineurin-dependent translocation of NFATc3 to the nucleus, which coincided with proliferation. Other Ca 2ϩ -dependent transcription factors, such as cAMP response element binding protein and Rho kinase, could also be involved (6, 35) .
The main finding of the present study is that inhibition of SR Ca 2ϩ release through IP 3 Rs in the form of Ca 2ϩ waves in cerebral arteries effectively blocks VSM cell proliferation. An important novel aspect of these studies is that they were performed with native arteries. Thus the findings presented here more closely resemble the cellular dynamics of in vivo VSM cell migration and proliferation. These results are significant because of their potential application in preventing pathological VSM cell proliferation. 
